Reference
Medicines and Healthcare products Regulatory Agency (UK). Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation. Drug Safety Update 12: 4-5, No. 6, Jan 2019. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770006/PDF-Jan-2019-publication.pdf
Rights and permissions
About this article
Cite this article
Gastrointestinal CMV infection/reactivation with ipilimumab. Reactions Weekly 1737, 2 (2019). https://doi.org/10.1007/s40278-019-57097-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57097-3